Tesamorelin + Ipamorelin is a dual-pathway growth hormone research blend combining a stabilized GHRH analog with a selective growth hormone secretagogue (GHS). Tesamorelin stimulates growth hormone release through GHRH receptor activation in the anterior pituitary, while Ipamorelin selectively targets the GHS-R1a receptor to promote endogenous GH signaling.
[99.8% PURITY COA TESTED]
Tesamorelin + Ipamorelin is a dual-pathway growth hormone research blend combining a stabilized GHRH analog with a selective growth hormone secretagogue (GHS). Tesamorelin stimulates growth hormone release through GHRH receptor activation in the anterior pituitary, while Ipamorelin selectively targets the GHS-R1a receptor to promote endogenous GH signaling.
[99.8% PURITY COA TESTED]